Showing results (1951-1960 of 3,051) with videos related to
Sort By:
Pageof 306
Theranostics|June 23, 2018
DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cellsJohannes Laengle, Judith Stift, Agnes Bilecz, et al.Clinical Lung Cancer|March 8, 2023
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II StudyMelissa L Johnson, James Strauss, Manish R Patel, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Exploring Size Exclusion Chromatography Columns 20 and 35 nm Pore Size Effect for Isolation of Extracellular VesiclesBalazs Kaszala, Vincenzo Scarsella, Kriti Bomb, et al.Biomedicines|April 29, 2025
Donor-Derived Cell-Free DNA Versus Left Ventricular Longitudinal Strain and Strain-Derived Myocardial Work Indices for Identification of Heart Transplant InjuryTimea Teszak, Timea Barcziova, Csaba Bödör, et al.International Journal of Oncology|March 5, 2011
Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitroYusuke Kitoh, Masanao Saio, Naoe Gotoh, et al.European Journal of Haematology|April 21, 2024
Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patientsEgyed Miklos, Tóth Peter Oliver, Kellner Adam, et al.Journal of Cardiovascular Pharmacology|April 13, 2004
Inhibition of ADP-evoked platelet aggregation by selected poly(ADP-ribose) polymerase inhibitorsTamas Alexy, Ambrus Toth, Zsolt Marton, et al.Skeletal Radiology|February 11, 2026
Metal-artifact reduced MR imaging for reverse shoulder arthroplasty: findings 1 year after surgeryPia M Jungmann, Martin Jaeger, Ferdinand C Wagner, et al.Journal of Molecular Neuroscience : MN|March 19, 2013
Protective effect of alpha-melanocyte-stimulating hormone (α-MSH) on the recovery of ischemia/reperfusion (I/R)-induced retinal damage in a rat modelBalazs Varga, Rudolf Gesztelyi, Mariann Bombicz, et al.Frontiers in Bioscience (Elite Edition)|December 29, 2009
Characterization of a novel, trastuzumab resistant human breast cancer cell lineMark Barok, Margit Balazs, Viktoria Lazar, et al.Pageof 306